Global Computational Medicine and Drug Discovery Software Market – Industry Analysis and Forecast (2020-2027) – By Tools, Application, and Geography

Global Computational Medicine and Drug Discovery Software Market is expected to reach US $ 0.89 Bn by 2027, at a CAGR of 3.5% during the forecast period. To know about the Research Methodology :- Request Free Sample Report Computational medicine includes a combination of engineering, mathematics, and computer science. The main aim of this field is to grow computational models for molecular biology, anatomy of disease, physiology, and apply these models to increase patient care. The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis. Drug discovery processes through which new medicines have been exposed. It includes different disciples such as chemistry, biology, and pharmacology. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding computational medicine and drug discovery software market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in computational medicine and drug discovery software market. Computational medicine and drug discovery software play a vital role in the development of drugs for several diseases such as cancer and other genetic disorders. Computational medicine also aids to detect the fault in the genes and consequently helps to predict the cause of the disease. Computational medicine and drug discovery software are used to realize the protein-protein interactions as well as protein-ligand interactions which makes it easier to catch the drug target. Computational medicine and drug discovery software market are estimated to witness a stable growth with growing research activities on drug designing and development. Given the usefulness in drug development, private as well as government companies are rising investment in R&D is expected to fuel growth in the computational medicine and drug discovery software market. Drug discovery and development composed are the complete process of identifying a new drug and bringing it to market. Discovery may include screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from a considerate of the target. Development includes studies on microorganisms and animals, clinical trials and ultimately regulatory support. The huge market share can be credited to the rising investments in R&D activities pertaining to drug discovery and development and disease modeling. Asia Pacific is estimated to highest CAGR during the forecast period owing to increasing adoption of technological innovations in the field of medicine. The market is projected to grow strongly across developing nations including China, Japan, and India.

Scope of the Global Computational Medicine and Drug Discovery Software Market: Inquire before buying

Global Computational Medicine and Drug Discovery Software Market by Tools

• Software • Databases • Others

Global Computational Medicine and Drug Discovery Software Market by Application

• Drug Discovery & Development • Disease Modeling • Medical Imaging • Others

Global Computational Medicine and Drug Discovery Software Market by Geography

• North America • Europe • Asia-Pacific • Middle East & Africa • South America

Key Players operating in the Global Computational Medicine and Drug Discovery Software Market

• Aurora Fine Chemicals LLC • Biognos AB • Certara LP. • Compugen Ltd. • Prosarix Ltd • Simulations Plus, Inc. • Schrodinger, LLC • FQS Poland • Labsolutions LLC • Entelos Inc • Crown Bioscience Inc • Chemical Computing Group Inc • Nimbus Therapeutics Inc • Dassault Systemes • Genedata Ag • Leadscope Inc • Rhenovia Pharma Limited • Entelos Inc. • Strand Life Sciences

Global Computational Medicine and Drug Discovery Software Market

1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Computational Medicine and Drug Discovery Software Market, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7.  Global Computational Medicine and Drug Discovery Software Market Industry Trends 5. Supply Side and Demand Side Indicators 6. Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast 6.1. Global Computational Medicine and Drug Discovery Software Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast, by Tools 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 7.4. Global Computational Medicine and Drug Discovery Software Market Size (US$ Bn) Forecast, by Tools 7.5. Global Computational Medicine and Drug Discovery Software Market Analysis, by Tools 7.6. Global Computational Medicine and Drug Discovery Software Market Attractiveness Analysis, by Tools 8. Global Computational Medicine and Drug Discovery Software Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 8.4. Global Computational Medicine and Drug Discovery Software Market Size (US$ Bn) Forecast, by Application 8.5. Global Computational Medicine and Drug Discovery Software Market Analysis, by Application 8.6. Global Computational Medicine and Drug Discovery Software Market Attractiveness Analysis, by Application 9. Global Computational Medicine and Drug Discovery Software Market Analysis, by Region 9.1. Global Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Region 9.2. Global Computational Medicine and Drug Discovery Software Market Size (US$ Bn) Forecast, by Region 9.3. Global Computational Medicine and Drug Discovery Software Market Attractiveness Analysis, by Region 10. North America Computational Medicine and Drug Discovery Software Market Analysis 10.1. Key Findings 10.2. North America Computational Medicine and Drug Discovery Software Market Overview 10.3. North America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 10.4. North America Computational Medicine and Drug Discovery Software Market Forecast, by Tools 10.4.1. Software 10.4.2. Databases 10.4.3. Others 10.5. North America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 10.6. North America Computational Medicine and Drug Discovery Software Market Forecast, by Application 10.6.1. Drug Discovery & Development 10.6.2. Disease Modeling 10.6.3. Medical Imaging 10.6.4. Others 10.7. North America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Country 10.8. North America Computational Medicine and Drug Discovery Software Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Computational Medicine and Drug Discovery Software Market Analysis, by Country 10.10. U.S. Computational Medicine and Drug Discovery Software Market Forecast, by Tools 10.10.1. Software 10.10.2. Databases 10.10.3. Others 10.11. U.S. Computational Medicine and Drug Discovery Software Market Forecast, by Application 10.11.1. Drug Discovery & Development 10.11.2. Disease Modeling 10.11.3. Medical Imaging 10.11.4. Others 10.12. Canada Computational Medicine and Drug Discovery Software Market Forecast, by Tools 10.12.1. Software 10.12.2. Databases 10.12.3. Others 10.13. Canada Computational Medicine and Drug Discovery Software Market Forecast, by Application 10.13.1. Drug Discovery & Development 10.13.2. Disease Modeling 10.13.3. Medical Imaging 10.13.4. Others 10.14. North America Computational Medicine and Drug Discovery Software Market Attractiveness Analysis 10.14.1. By Tools 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Developments 11. Europe Computational Medicine and Drug Discovery Software Market Analysis 11.1. Key Findings 11.2. Europe Computational Medicine and Drug Discovery Software Market Overview 11.3. Europe Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 11.4. Europe Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.4.1. Software 11.4.2. Databases 11.4.3. Others 11.5. Europe Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 11.6. Europe Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.6.1. Drug Discovery & Development 11.6.2. Disease Modeling 11.6.3. Medical Imaging 11.6.4. Others 11.7. Europe Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Country 11.8. Europe Computational Medicine and Drug Discovery Software Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Computational Medicine and Drug Discovery Software Market Analysis, by Country 11.10. Germany Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.10.1. Software 11.10.2. Databases 11.10.3. Others 11.11. Germany Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.11.1. Drug Discovery & Development 11.11.2. Disease Modeling 11.11.3. Medical Imaging 11.11.4. Others 11.12. U.K. Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.12.1. Software 11.12.2. Databases 11.12.3. Others 11.13. U.K. Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.13.1. Drug Discovery & Development 11.13.2. Disease Modeling 11.13.3. Medical Imaging 11.13.4. Others 11.14. France Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.14.1. Software 11.14.2. Databases 11.14.3. Others 11.15. France Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.15.1. Drug Discovery & Development 11.15.2. Disease Modeling 11.15.3. Medical Imaging 11.15.4. Others 11.16. Italy Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.16.1. Software 11.16.2. Databases 11.16.3. Others 11.17. Italy Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.17.1. Drug Discovery & Development 11.17.2. Disease Modeling 11.17.3. Medical Imaging 11.17.4. Others 11.18. Spain Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.18.1. Software 11.18.2. Databases 11.18.3. Others 11.19. Spain Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.19.1. Drug Discovery & Development 11.19.2. Disease Modeling 11.19.3. Medical Imaging 11.19.4. Others 11.20. Rest of Europe Computational Medicine and Drug Discovery Software Market Forecast, by Tools 11.20.1. Software 11.20.2. Databases 11.20.3. Others 11.21. Rest Of Europe Computational Medicine and Drug Discovery Software Market Forecast, by Application 11.21.1. Drug Discovery & Development 11.21.2. Disease Modeling 11.21.3. Medical Imaging 11.21.4. Others 11.22. Europe Computational Medicine and Drug Discovery Software Market Attractiveness Analysis 11.22.1. By Tools 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trends 11.25. Key Developments 12. Asia Pacific Computational Medicine and Drug Discovery Software Market Analysis 12.1. Key Findings 12.2. Asia Pacific Computational Medicine and Drug Discovery Software Market Overview 12.3. Asia Pacific Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 12.4. Asia Pacific Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.4.1. Software 12.4.2. Databases 12.4.3. Others 12.5. Asia Pacific Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 12.6. Asia Pacific Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.6.1. Drug Discovery & Development 12.6.2. Disease Modeling 12.6.3. Medical Imaging 12.6.4. Others 12.7. Asia Pacific Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Country 12.8. Asia Pacific Computational Medicine and Drug Discovery Software Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Computational Medicine and Drug Discovery Software Market Analysis, by Country 12.10. China Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.10.1. Software 12.10.2. Databases 12.10.3. Others 12.11. China Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.11.1. Drug Discovery & Development 12.11.2. Disease Modeling 12.11.3. Medical Imaging 12.11.4. Others 12.12. India Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.12.1. Software 12.12.2. Databases 12.12.3. Others 12.13. India Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.13.1. Drug Discovery & Development 12.13.2. Disease Modeling 12.13.3. Medical Imaging 12.13.4. Others 12.14. Japan Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.14.1. Software 12.14.2. Databases 12.14.3. Others 12.15. Japan Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.15.1. Drug Discovery & Development 12.15.2. Disease Modeling 12.15.3. Medical Imaging 12.15.4. Others 12.16. ASEAN Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.16.1. Software 12.16.2. Databases 12.16.3. Others 12.17. ASEAN Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.17.1. Drug Discovery & Development 12.17.2. Disease Modeling 12.17.3. Medical Imaging 12.17.4. Others 12.18. Rest of Asia Pacific Computational Medicine and Drug Discovery Software Market Forecast, by Tools 12.18.1. Software 12.18.2. Databases 12.18.3. Others 12.19. Rest of Asia Pacific Computational Medicine and Drug Discovery Software Market Forecast, by Application 12.19.1. Drug Discovery & Development 12.19.2. Disease Modeling 12.19.3. Medical Imaging 12.19.4. Others 12.20. Asia Pacific Computational Medicine and Drug Discovery Software Market Attractiveness Analysis 12.20.1. By Tools 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trends 12.23. Key Developments 13. Middle East & Africa Computational Medicine and Drug Discovery Software Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Computational Medicine and Drug Discovery Software Market Overview 13.3. Middle East & Africa Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 13.4. Middle East & Africa Computational Medicine and Drug Discovery Software Market Forecast, by Tools 13.4.1. Software 13.4.2. Databases 13.4.3. Others 13.5. Middle East & Africa Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 13.6. Middle East & Africa Computational Medicine and Drug Discovery Software Market Forecast, by Application 13.6.1. Drug Discovery & Development 13.6.2. Disease Modeling 13.6.3. Medical Imaging 13.6.4. Others 13.7. Middle East & Africa Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Country 13.8. Middle East & Africa Computational Medicine and Drug Discovery Software Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Computational Medicine and Drug Discovery Software Market Analysis, by Country 13.10. GCC Computational Medicine and Drug Discovery Software Market Forecast, by Tools 13.10.1. Software 13.10.2. Databases 13.10.3. Others 13.11. GCC Computational Medicine and Drug Discovery Software Market Forecast, by Application 13.11.1. Drug Discovery & Development 13.11.2. Disease Modeling 13.11.3. Medical Imaging 13.11.4. Others 13.12. South Africa Computational Medicine and Drug Discovery Software Market Forecast, by Tools 13.12.1. Software 13.12.2. Databases 13.12.3. Others 13.13. South Africa Computational Medicine and Drug Discovery Software Market Forecast, by Application 13.13.1. Drug Discovery & Development 13.13.2. Disease Modeling 13.13.3. Medical Imaging 13.13.4. Others 13.14. Rest of Middle East & Africa Computational Medicine and Drug Discovery Software Market Forecast, by Tools 13.14.1. Software 13.14.2. Databases 13.14.3. Others 13.15. Rest of Middle East & Africa Computational Medicine and Drug Discovery Software Market Forecast, by Application 13.15.1. Drug Discovery & Development 13.15.2. Disease Modeling 13.15.3. Medical Imaging 13.15.4. Others 13.16. Middle East & Africa Computational Medicine and Drug Discovery Software Market Attractiveness Analysis 13.16.1. By Tools 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trends 13.19. Key Developments 14. South America Computational Medicine and Drug Discovery Software Market Analysis 14.1. Key Findings 14.2. South America Computational Medicine and Drug Discovery Software Market Overview 14.3. South America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Tools 14.4. South America Computational Medicine and Drug Discovery Software Market Forecast, by Tools 14.4.1. Software 14.4.2. Databases 14.4.3. Others 14.5. South America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Application 14.6. South America Computational Medicine and Drug Discovery Software Market Forecast, by Application 14.6.1. Drug Discovery & Development 14.6.2. Disease Modeling 14.6.3. Medical Imaging 14.6.4. Others 14.7. South America Computational Medicine and Drug Discovery Software Market Value Share Analysis, by Country 14.8. South America Computational Medicine and Drug Discovery Software Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. South America Computational Medicine and Drug Discovery Software Market Analysis, by Country 14.10. Brazil Computational Medicine and Drug Discovery Software Market Forecast, by Tools 14.10.1. Software 14.10.2. Databases 14.10.3. Others 14.11. Brazil Computational Medicine and Drug Discovery Software Market Forecast, by Application 14.11.1. Drug Discovery & Development 14.11.2. Disease Modeling 14.11.3. Medical Imaging 14.11.4. Others 14.12. Mexico Computational Medicine and Drug Discovery Software Market Forecast, by Tools 14.12.1. Software 14.12.2. Databases 14.12.3. Others 14.13. Mexico Computational Medicine and Drug Discovery Software Market Forecast, by Application 14.13.1. Drug Discovery & Development 14.13.2. Disease Modeling 14.13.3. Medical Imaging 14.13.4. Others 14.14. Rest of South America Computational Medicine and Drug Discovery Software Market Forecast, by Tools 14.14.1. Software 14.14.2. Databases 14.14.3. Others 14.15. Rest of South America Computational Medicine and Drug Discovery Software Market Forecast, by Application 14.15.1. Drug Discovery & Development 14.15.2. Disease Modeling 14.15.3. Medical Imaging 14.15.4. Others 14.16. South America Computational Medicine and Drug Discovery Software Market Attractiveness Analysis 14.16.1. By Tools 14.16.2. By Application 14.17. PEST Analysis 14.18. Key Trends 14.19. Key Developments 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Aurora Fine Chemicals LLC 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Development Footprint 15.3.2. Biognos AB 15.3.3. Certara LP. 15.3.4. Compugen Ltd. 15.3.5. Prosarix Ltd 15.3.6. Simulations Plus, Inc. 15.3.7. Schrodinger, LLC 15.3.8. FQS Poland 15.3.9. Labsolutions LLC 15.3.10. Entelos Inc 15.3.11. Crown Bioscience Inc 15.3.12. Chemical Computing Group Inc 15.3.13. Nimbus Therapeutics Inc 15.3.14. Dassault Systemes 15.3.15. Genedata Ag 15.3.16. Leadscope Inc 15.3.17. Rhenovia Pharma Limited 15.3.18. Entelos Inc. 15.3.19. Strand Life Sciences 16. Primary Key Insights

About This Report

Report ID25395
Category Information Technology & Telecommunication
Published DateJAN 2020
Updated Date
Contact Us